ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

Verrica Pharmaceuticals

Official 2024 U.S. DOL Form 5500 summary for Verrica Pharmaceuticals (Verrica Pharmaceuticals 401(k) · EIN 46-3137900 · PN 001): $5.75M net assets, 102 active participants, and $42.15 per $10,000 (42.15 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorVerrica Pharmaceuticals
Filing IdentifierVerrica Pharmaceuticals 401(k) · EIN 46-3137900 · PN 001
Plan Category & State401(k) Defined Contribution (PA)
Asset-Size Peer Cohort$1M-$5M
Plan Net Assets (2024)$5.75M
Active Participants102
Direct Admin Fee Rate$42.15 per $10,000 (42.15 bps)
Cohort Peer Median$63.02 per $10,000 (63.02 bps)
Primary Recordkeeper / ProviderEquity Services INC
Schedule H Line 4a RemittanceSchedule H Line 4a Late Remittance Reported ($143,855, often administrative timing)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI